Where does Medtronic Ireland Manufacturing Unlimited Company rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medtronic Ireland Manufacturing Unlimited Company ranks #7,587 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Medtronic Ireland Manufacturing Unlimited Company's Innovation Score?

Medtronic Ireland Manufacturing Unlimited Company has an Innovation Score of 57.9 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medtronic Ireland Manufacturing Unlimited Company focus on?

Medtronic Ireland Manufacturing Unlimited Company's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 43 patents, ranking #444 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Medtronic Ireland Manufacturing Unlimited Company's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Medtronic Ireland Manufacturing Unlimited Company.

What does claim depth mean for Medtronic Ireland Manufacturing Unlimited Company's patents?

Medtronic Ireland Manufacturing Unlimited Company's patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medtronic Ireland Manufacturing Unlimited Company

Q: How many patents does Medtronic Ireland Manufacturing Unlimited Company hold?

Medtronic Ireland Manufacturing Unlimited Company holds 43 US utility patents granted between 2023 and 2025, spanning 13 technology areas.

Q: How is the Medtronic Ireland Manufacturing Unlimited Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 43 granted patents across 13 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medtronic ranks #7,587 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 13 technology areas.

#7,587
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.9/100): 20.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7587 · Foreign Corporation #7,587 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 43 grants
UPPER-Q #7,587/49,997
PHOTO-FINISH Medical Research…
CPC-FOCUS A61B · 13 areas
INNOV-PAR 57.9/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Medical Research Council (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medtronic’s 57.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (23%) Velocity 20.0 pts (35%) Breadth 12.7 pts (22%) Claim depth 12.1 pts (21%)

Qualcomm Incorporated · highest

85
Cigna Intellectual… · near

58
Medtronic Ireland… · this assignee

58
THE University OF… · near

58
Unirac · near

58
Alpha and Omega… · near

58
3D Lighting… · lowest

7

What this shows Medtronic's Innovation Score is 57.9/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medtronic?

Each dot is one of Medtronic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtronic’s own 20.2 claims/patent is ABOVE the 10.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medtronic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medtronic's grants concentrate

Medtronic Ireland Manufacturing Unlimited Company is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (21 grants) versus a trough of 10 in 2023. By volume, Medtronic sits between Miltenyi Biotec B.V. & Co. KG and National University Corporation Kyoto Institute OF Technology.

Medtronic's three-year grant acceleration

Medtronic Ireland Manufacturing Unlimited Company shows 31 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Miltenyi Biotec B…

43
Miyakoshi Printin…

43
Mobotix

43
Medical Research…

43
Mimosa Networks

43
Myscript

43
Nabtesco Automoti…

43
National Universi…

43
Medtronic Ireland… ◀

43

What this shows Medtronic holds 43 patents at rank #7,591, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medtronic

By rank, the assignees closest to #7,591 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medtronic's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medtronic, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medtronic ranks #444 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

Cigna Intellectual Property, Inc. 58 THE University OF Liverpool 58 Unirac, Inc. 58 Alpha and Omega Semiconductor International LP 58

Medtronic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Medtronic Ireland Manufacturing Unlimited Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	10	23.3%
2024	21	48.8%
2025partial year	12	27.9%

Which technologies does Medtronic Ireland Manufacturing Unlimited Company patent most?

A61B - DIAGNOSIS; SURGERY; Identification 43

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 32

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 11

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G06N - Computing Arrangements Based ON Specific Computational Models 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12Y - Enzymes 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Y10T - Technical Subjects Covered BY Former US Classification 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medtronic Ireland Manufacturing Unlimited Company's patent record in context - here's where to go next.

Medtronic Ireland Manufacturing Unlimited Company's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #7,587 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medtronic Ireland Manufacturing Unlimited Company against Miltenyi Biotec B.V. & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.